Skip to content

Clinical trials

Systemic Inflammatory Response Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Systemic Inflammatory Response Syndrome Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20113
20121
20144
20151
20182
20211
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Completed5
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital3
Beijing Anzhen Hospital2
Air Force Military Medical University, China1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
First Affiliated Hospital Xi'an Jiaotong University1
Guohua Zeng1
Nanjing Medical University1
Peking Union Medical College Hospital1
Peking University1
Ruijin Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Systemic Inflammatory Response Syndrome17
Sepsis6
Multiple Organ Failure2
Pancreatitis2
Postoperative Complications2
Shock, Septic2
Aortic Dissection1
Candidemia1
Candidiasis1
Candidiasis, Invasive1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.